跳至主要内容
临床试验/NCT02669420
NCT02669420已完成2 期

Intra Uterine Extra Amniotic (200 μg ) Versus Vaginal (200 μg) Misoprostol for Second Trimester Pregnancy Termination: Randomized Controlled Trial

Assiut University0 个研究点目标入组 180 人开始时间: 2015年1月最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
180
主要终点
mean duration from the initial misoprostol dose until complete fetal expulsion

研究概览

简要总结

The majority of second-trimester pregnancy termination performed in the United States are performed surgically by dilation and evacuation. The frequency of induction of abortion increases as gestational age advances. In the late second trimester and early third trimester, induction is the primary method of termination in cases of fetal abnormalities. In many other countries, however, induction is the primary method of abortion throughout the second trimester

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

性别
Female
接受健康志愿者

入选标准

  • Pregnancy 13-24 weeks.
  • Women with indication for termination of the pregnancy due to intra uterine fetal death

排除标准

  • Pregnancy before 13 weeks.
  • Pregnancy beyond 24 weeks.
  • Women with scared uterus.
  • Known hypersensitivity for misoprostol.
  • Refusal of the woman to participate.

结局指标

主要结局

mean duration from the initial misoprostol dose until complete fetal expulsion

时间窗: 24 hours

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

abo bakr mitwally

lecturer

Assiut University

相似试验